← Back to Analyst Consensus 
VRCA Buy
Verrica Pharmaceuticals Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 18, 2025 | Brookline Capital | upgrade | Hold → Buy | $17 | 38% |
| May 14, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Apr 9, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Apr 8, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Mar 12, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Dec 20, 2024 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Nov 6, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Nov 5, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Nov 5, 2024 | RBC Capital | downgrade | Outperform → Sector Perform | $2 | 55% |
| Oct 21, 2024 | TD Cowen | maintain | Buy → Buy | $10 | 54% |
| Oct 4, 2024 | RBC Capital | maintain | Outperform → Outperform | $11 | 55% |
| Oct 3, 2024 | Needham | downgrade | Buy → Hold | $12 | 50% |
| Oct 2, 2024 | Brookline Capital | downgrade | Buy → Hold | $0 | 38% |
| Aug 15, 2024 | RBC Capital | maintain | Outperform → Outperform | $13 | 55% |
| Aug 15, 2024 | Needham | maintain | Buy → Buy | $12 | 50% |
| May 16, 2024 | Needham | reiterate | Buy → Buy | $16 | 50% |
| May 14, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $14 | 44% |
| May 14, 2024 | Needham | maintain | Buy → Buy | $16 | 50% |
| Apr 10, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Mar 1, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Mar 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Dec 15, 2023 | Jefferies | reiterate | Buy → Buy | $10 | 52% |
| Nov 10, 2023 | Needham | maintain | Buy → Buy | $8 | 50% |
| Oct 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 23, 2023 | Needham | reiterate | Buy → Buy | $10 | 50% |
| Aug 10, 2023 | Needham | reiterate | Buy → Buy | $10 | 50% |
| Jul 27, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Jul 25, 2023 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| Jul 25, 2023 | Needham | upgrade | Hold → Buy | $10 | 50% |
| Jul 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Mar 22, 2023 | Jefferies | initiate | — → Buy | $10 | 52% |
| Mar 7, 2023 | RBC Capital | reiterate | — → Outperform | $11 | 55% |
| Feb 13, 2023 | RBC Capital | upgrade | Sector Perform → Outperform | $11 | 55% |
| May 31, 2022 | HC Wainwright & Co. | maintain | — → Buy | $12 | 44% |
| May 25, 2022 | RBC Capital | downgrade | Outperform → Sector Perform | $4 | 55% |
| Mar 10, 2022 | Brookline Capital | initiate | — → Buy | $20 | 38% |
| Mar 3, 2022 | Needham | maintain | — → Buy | $18 | 50% |
| Sep 22, 2021 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| Sep 21, 2021 | RBC Capital | maintain | — → Outperform | $16 | 55% |
| Sep 21, 2021 | Needham | maintain | — → Buy | $20 | 50% |
| May 14, 2021 | RBC Capital | initiate | — → Outperform | $19 | 55% |
| Mar 8, 2021 | HC Wainwright & Co. | maintain | — → Buy | $24 | 44% |
| Feb 17, 2021 | Needham | maintain | — → Buy | $22 | 50% |
| Jul 15, 2020 | B of A Securities | downgrade | Buy → Neutral | $10 | 53% |
| Jun 30, 2020 | HC Wainwright & Co. | maintain | — → Buy | $18 | 44% |
| Jun 30, 2020 | Needham | maintain | — → Buy | $17 | 50% |
| Jun 24, 2020 | Northland Capital Markets | initiate | — → Outperform | $21 | 50% |
| Mar 24, 2020 | Needham | initiate | — → Buy | $0 | 50% |
| Feb 21, 2019 | HC Wainwright & Co. | initiate | — → Buy | $20 | 44% |
| Jul 10, 2018 | Jefferies | initiate | — → Buy | $24 | 52% |
Price Target Trend
Apr 20, 2026 Latest: $13.83 Oct 23, 2026
EPS Estimates
0y $-1.88
Lo: $-2.03 Hi: $-1.70
4 analysts 0q $-0.49
Lo: $-0.54 Hi: $-0.46
4 analysts +1q $-0.45
Lo: $-0.51 Hi: $-0.36
4 analysts +1y $-1.24
Lo: $-1.50 Hi: $-0.85
4 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days